#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA5238624	F	Antiviral activity against wild type HIV-1 IIIB infected in human MT4 cells assessed as protection against virus-induced cytopathic effect incubated for 5 days by MTT assay	Human immunodeficiency virus 1	46		organism-based format	Scientific Literature
2.	ALA5238625	F	Antiviral activity against HIV-1 RES056 harboring RT K103N/Y181C double mutant infected in human MT4 cells assessed as protection against virus-induced cytopathic effect incubated for 5 days by MTT assay	Human immunodeficiency virus 1	46		organism-based format	Scientific Literature
3.	ALA5238626	T	Cytotoxicity against human MT4 cells assessed as reduction in cell viability measured after 5 days by MTT assay	Homo sapiens	46		cell-based format	Scientific Literature
4.	ALA5238627	T	Selectivity index, ratio of CC50 for cytotoxicity against human MT4 cells to EC50 for antiviral activity against wild type HIV-1 IIIB infected in human MT4 cells		46		cell-based format	Scientific Literature
5.	ALA5238628	T	Selectivity index, ratio of CC50 for cytotoxicity against human MT4 cells to EC50 for antiviral activity against HIV-1 RES056 harboring RT K103N/Y181C double mutant infected in human MT4 cells		46		cell-based format	Scientific Literature
6.	ALA5238629	F	Antiviral activity against HIV-1 harboring RT L100I mutant infected in human MT4 cells assessed as protection against virus-induced cytopathic effect incubated for 5 days by MTT assay	Human immunodeficiency virus 1	6		organism-based format	Scientific Literature
7.	ALA5238630	F	Antiviral activity against HIV-1 harboring RT K103N mutant infected in human MT4 cells assessed as protection against virus-induced cytopathic effect incubated for 5 days by MTT assay	Human immunodeficiency virus 1	6		organism-based format	Scientific Literature
8.	ALA5238631	F	Antiviral activity against HIV-1 harboring RT Y181C mutant infected in human MT4 cells assessed as protection against virus-induced cytopathic effect incubated for 5 days by MTT assay	Human immunodeficiency virus 1	6		organism-based format	Scientific Literature
9.	ALA5238632	F	Antiviral activity against HIV-1 harboring RT Y188L mutant infected in human MT4 cells assessed as protection against virus-induced cytopathic effect incubated for 5 days by MTT assay	Human immunodeficiency virus 1	6		organism-based format	Scientific Literature
10.	ALA5238633	F	Antiviral activity against HIV-1 harboring RT E138K mutant infected in human MT4 cells assessed as protection against virus-induced cytopathic effect incubated for 5 days by MTT assay	Human immunodeficiency virus 1	6		organism-based format	Scientific Literature
11.	ALA5238634	F	Antiviral activity against HIV-1 harboring RT F227L/V106A double mutant infected in human MT4 cells assessed as protection against virus-induced cytopathic effect incubated for 5 days by MTT assay	Human immunodeficiency virus 1	6		organism-based format	Scientific Literature
12.	ALA5238635	F	Potency index, ratio of Etravirine EC50 to test compound EC50 for antiviral activity against HIV-1 harboring RT K103N mutant infected in human MT4 cells assessed as protection against virus-induced cytopathic effect incubated for 5 days by MTT assay	Human immunodeficiency virus 1	1		organism-based format	Scientific Literature
13.	ALA5238636	F	Potency index, ratio of Etravirine EC50 to test compound EC50 for antiviral activity against HIV-1 harboring RT E138K mutant infected in human MT4 cells assessed as protection against virus-induced cytopathic effect incubated for 5 days by MTT assay	Human immunodeficiency virus 1	1		organism-based format	Scientific Literature
14.	ALA5238638	B	Inhibition of wild type recombinant HIV-1 reverse transcriptase using biotin-labelled dNTPs as substrate assessed as inhibition of biotin-labelled UTP incorporation incubated for 1 hr by ELISA	Human immunodeficiency virus 1	5		single protein format	Scientific Literature